RSA Viewpoints
What should pharma companies learn from the pandemic? Volume 1
Now is the opportunity for leaders to create essential change
I’m often asked: “How are the best leaders behaving?” I observe that quicker decision-making, simplicity...
Key Learnings from the Coronavirus Challenge and innovating for a sustainable future
The life science sector is under extreme pressure to meet the global need for better, faster therapies to combat COVID-19 and The BIA is...
Interim managers can help when international travel is restricted
As the world faces an unprecedented global shutdown amid the COVID-19 pandemic, for life sciences companies it’s in the interests of everyone, not least...
IR35 postponement makes Interim Executives an option once again
This week’s government decision to postpone the implementation of the Off-Payroll Tax (IR35) to the private sector until April 2021 is a welcome announcement...
Considerations for leaders: managing teams remotely
Following last week’s announcement by the World Health Organisation that the spread of Covid-19 has officially reached ‘pandemic’ status, more and more companies are...
Could a different approach to head office teams drive better efficiency?
When done right, an interim manager can provide a cost-effective way to access the best talent to deliver a flexible solution, whilst transferring skills...
Nurturing new talent – top 5 benefits of an internship
The job market is becoming more and more competitive. Students who have spent the twilight of their teenage years grinding out essays in College...
JPM 2020 l The changing landscape of global healthcare in the new decade
I was struck by a resounding shift in attitude at this year’s J.P. Morgan Healthcare Conference; less talk, more action. The atmosphere felt more...
Life science talent in China’s booming life science sector
Whatever statistics one reads about China, they never fail to impress with their scale and rate of growth. In 2007, China was the world’s...
Cell and Gene Therapy – leadership teams must grow fast
This is a great time for companies developing new cell and gene therapy medicines. The industry will need many more skilled people as the...
Private sector IR35 update on the horizon yet in change lies opportunity
Interim Management is the means by which an individual provides professional services to a client-base of their choosing. It is typically delivered by highly...
Attracting the Best Life Sciences Talent After Brexit
One of the reasons that the UK is a leader in life sciences has been its ability to attract, develop and retain a highly...
IQ might get you hired but EQ will get you promoted
The rise of EQ is interesting because it goes hand in hand with technological and sociological evolution. 20-30 years ago, leaders were sought (predominately)...
Who can put a price on cell and gene therapy?
Insights from the Endpoints UK Biotech Summit October 2019 Fifteen years ago, Health Economics Outcomes Research (HEOR) was the pharma industry’s new kid on...
Unleashing The Power of Interims
Businesses are dynamic; they grow, contract, fail and succeed. Research has firmly established that this process is vital to productivity and sustained growth in...
RSA Talent Talks debut Podcast
We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...
The Human Factor in MedTech
The medtech industry is growing rapidly, with projected compound annual growth rates of 5.6% worldwide from 2017, reaching $595 billion by 2024. This raises the...